Premium
Daikenchuto prevention of postoperative ileus after retroperitoneal lymph node dissection in advanced childhood testicular yolk sac tumor
Author(s) -
Johnin Kazuyoshi,
Takahashi Kentaro,
Kawauchi Akihiro
Publication year - 2018
Publication title -
traditional and kampo medicine
Language(s) - English
Resource type - Journals
ISSN - 2053-4515
DOI - 10.1002/tkm2.1091
Subject(s) - medicine , ileus , dissection (medical) , surgery , yolk sac , chemotherapy , lymph node , retroperitoneal lymph node dissection , adjuvant chemotherapy , cancer , testicular cancer , embryo , biology , microbiology and biotechnology , breast cancer
Case A 2‐year‐old boy with advanced testicular yolk sac tumor needed adjuvant chemotherapy immediately after retroperitoneal lymph node dissection. From postoperative day 1, daikenchuto (DKT) was given transrectally and orally. Outcome On postoperative day 7, the patient underwent adjuvant chemotherapy without having postoperative ileus. He has been free from disease recurrence for 8 years after completion of the final chemotherapy without developmental or gait disturbance. Conclusion To prevent postoperative ileus, it is feasible for DKT to be given transrectally and orally even in small children.